NDC 72769-181

Rapivab

Peramivir

Rapivab is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Biocryst Pharmaceuticals, Inc.. The primary component is Peramivir.

Product ID72769-181_4fd5d946-6027-4662-b66b-9ccd68f446b7
NDC72769-181
Product TypeHuman Prescription Drug
Proprietary NameRapivab
Generic NamePeramivir
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-12-20
Marketing CategoryNDA / NDA
Application NumberNDA206426
Labeler NameBioCryst Pharmaceuticals, Inc.
Substance NamePERAMIVIR
Active Ingredient Strength600 mg/60mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72769-181-03

3 VIAL, GLASS in 1 CARTON (72769-181-03) > 20 mL in 1 VIAL, GLASS (72769-181-01)
Marketing Start Date2014-12-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Rapivab" or generic name "Peramivir"

NDCBrand NameGeneric Name
61364-181Rapivabperamivir
72769-181Rapivabperamivir

Trademark Results [Rapivab]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RAPIVAB
RAPIVAB
86141883 4778059 Live/Registered
SEQIRUS UK LIMITED
2013-12-12
RAPIVAB
RAPIVAB
85105828 not registered Dead/Abandoned
BioCryst Pharmaceuticals, Inc.
2010-08-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.